Iron is an essential trace mineral necessary for life, and iron deficiency anaemia (IDA) is one
of the most common haematological problems worldwide, affecting a sixth of the global …

Among end‐stage renal disease patients maintained by hemodialysis, anemia has been
managed primarily through erythropoiesis‐stimulating agents (ESAs) and intravenous (IV) …

Results Of 13,249 eligible patients, 1320 (10%) died and 1627 (12%) had one or more
infection-related events during the 4-month follow-up. The most and least commonly initiated …

Background Anemia at hemodialysis (HD) initiation is common. Correcting low hemoglobin
(Hgb) before HD initiation may improve survival by avoiding potential harms of chronic …

Background The optimal treatment algorithm for iron therapy and the use of erythropoiesis-
stimulating agents (ESA) in anemic hemodialysis (HD) patients has not been established …

Background Iron is administered intravenously (IV) to many dialysis patients at regular
intervals and iron stores are evaluated through periodic measurements of ferritin and …

Methods We retrospectively reviewed the patients receiving HD at Kosin University Gospel
Hospital. The patients were divided into two groups, an IV iron supplementation group and a …

我国慢性肾脏病贫血患者存在铁缺乏患病率高, 诊断不足, 铁代谢指标达标率低,
监测手段及治疗不规范等问题. 基于当前诊疗现状, 本指南由肾脏病, 血液净化, 血液病, 药学 …

Anemia is a common condition observed in chronic disease states and in these chronically
ill patients has a negative impact on their quality of life and survival. Various cytokines and …

Hintergrund Eisennanopartikel wurden zur Behandlung von Eisenmangelanämie entwickelt
und werden intravenös eingesetzt. Unter ihnen wurde 1949 Eisensaccharose (IS)(Venofer® …